WAT Waters Corporation

WAT Waters Corporation

Healthcare · Diagnostics & Research

Market read

POC $375.96 · VWAP $343.07 · +18.9% vs 12m avg buyer

uptrend vol: normalgaps: overnight-shiftchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

2 watchlists

Watchlists @biotech-capital-cycle@trace-glp1-manufacturing

WAT Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist WAT belongs to, members best 30-day change first — WAT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@trace-glp1-manufacturing
View watchlist →
BDX+15.1% -0.7%1d +1.4%7d STVN+10.9% +0.9%1d +3.6%7d WAT+10.5% -1.1%1d -1.0%7d TMO+10.0% -0.5%1d -2.3%7d STE+5.5% -1.5%1d -3.9%7d BANB.SW+5.2% -0.5%1d +0.5%7d DHR-0.6% +0.1%1d -3.2%7d LZAGY-0.7% +0.9%1d -2.4%7d WST-3.3% -0.8%1d -1.6%7d
@biotech-capital-cycle
View watchlist →
ABCL+73.1% -1.6%1d +19.9%7d TXG+32.6% +3.4%1d -1.1%7d TWST+32.6% +4.9%1d -0.3%7d CRL+27.8% +2.4%1d +3.4%7d ALMR+23.8% -3.1%1d +14.8%7d AVTR+21.9% -1.2%1d -1.6%7d IQV+17.0% +1.9%1d -0.2%7d GENB+15.7% +0.3%1d +6.6%7d CERT+15.4% 0.0%1d -0.9%7d RGEN+14.8% +1.3%1d +3.6%7d SDGR+13.6% -1.1%1d -7.4%7d A+12.9% -0.1%1d -0.2%7d ABSI+11.3% +0.7%1d +2.5%7d MEDP+11.0% +3.2%1d -0.9%7d WAT+10.5% -1.1%1d -1.0%7d TMO+10.0% -0.5%1d -2.3%7d MTD+8.2% -0.1%1d -0.6%7d RXRX+5.8% -1.6%1d -5.2%7d RVTY+5.5% -0.6%1d +0.1%7d ILMN+3.5% +1.2%1d +0.7%7d XBI+3.4% +1.4%1d +1.0%7d FTRE+1.9% +4.0%1d -4.6%7d SLP+0.7% +0.1%1d +0.1%7d ICLR-0.3% +3.9%1d +2.0%7d DHR-0.6% +0.1%1d -3.2%7d BRKR-1.0% -0.1%1d +2.4%7d TEM-1.6% -0.9%1d -6.2%7d SEER-6.5% -2.4%1d -5.5%7d VKTX-9.3% +1.3%1d -2.2%7d QSI-9.8% 0.0%1d -6.3%7d DNA-12.5% +1.9%1d -9.4%7d AGIO-15.1% +0.2%1d +3.1%7d PACB-16.0% +5.2%1d +4.3%7d LAB-23.6% -4.2%1d -11.5%7d QTRX-24.6% +12.7%1d +21.2%7d CDXS-29.0% +1.9%1d +7.4%7d NAUT-49.4% -1.1%1d +2.3%7d

Next earnings WAT reports in 73 days Oct 30

Last report May 5

Reported the quarter ending 2026-04-04: revenue $1.27B, diluted EPS $-0.87, net income $-72M (SEC filing). Across the print the stock moved +15.8% (close before → first close after).

full note →

Against street estimates

How WAT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 4 · projection Aug 17

Result
Aug 4 3.013.05+1.4%In line
May 5 2.312.70 GAAP ≠ +17.0%Beat
Feb 9 4.514.53+0.5%In line
Nov 4 '25 3.223.40 GAAP ≠ +5.5%Beat
Aug 4 '25 2.942.95+0.3%In line
May 6 '25 2.222.25+1.2%In line
Feb 12 '25 4.034.10+1.7%In line
Nov 1 '24 2.682.93+9.4%Beat

News (last pull)

Headlines about WAT from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 111 days ago · Apr 29 · last pull reported an error, so these may be older than they look

WAT research tape

8 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Monster Scan — 2026-08-14 scan Monster Scan — 2026-08-13 scan Monster Scan — 2026-08-12 scan Monster Scan — 2026-08-08 earnings WAT earnings — 2026-08-04
Types
Aug 14 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABCL +4 more
Aug 13 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABCL +4 more
Aug 12 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABCL +4 more
Aug 8 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAALAAMIAAOIABBNY +4 more
Aug 4 Catalyst WAT earnings
WAT
Jul 29 Catalyst WAT earnings
WAT
May 6 Deep Dive WAT
WAT
May 5 Catalyst WAT earnings
WAT